Angiotensin receptor blockers (ARBs) vs angiotensin‐converting enzyme inhibitors (ACEis)
Micro‐ to normoalbuminuria Median · people with diabetes and kidney disease
Angiotensin receptor blockers showed no clear difference in micro‐ to normoalbuminuria Median compared with angiotensin‐converting‐enzyme inhibitors (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 0.96 [0.62, 1.48]4 studies · 216 participantsLow